This site is intended for health professionals only

Actavis brings escitalopram to market

Actavis has launched escitalopram tablets, which further strengthens Actavis’ portfolio of over 750 generic medicines across a wide variety of therapy areas.

Escitalopram is indicated for the treatment of major depressive episodes, panic disorders, with or without agoraphobia, social anxiety disorder and obsessive compulsive disorder (OCD).

Article continues below this sponsored advert
Cogora InRead Image
Explore the latest advances in respiratory care at events delivered by renowned experts from CofE
Advertisement

Actavis has launched escitalopram tablets, which further strengthens Actavis’ portfolio of over 750 generic medicines across a wide variety of therapy areas.

Escitalopram is indicated for the treatment of major depressive episodes, panic disorders, with or without agoraphobia, social anxiety disorder and obsessive compulsive disorder (OCD).

Actavis is offering escitalopram tablets in 5mg, 10mg and 20mg strength packs of 28 tablets. All products are available through major wholesalers or directly from the Actavis Telemarketing team (freephone: 0800 731 0370; fax: 0800 731 0380).

Jonathan Wilson, Executive Director UK, commented: “Actavis continues to be first to market offering the high-quality pharmaceuticals expected of a leading UK manufacturer with over 175 years’ experience in healthcare. We are committed to providing pharmacy with increased choice and competitively priced medicines.”






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x